Delivery Order SPE2DB25D3404-SPE2DB25FUPLW
- Not listed
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,259.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.92 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This firm fixed-price delivery order, issued on July 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,499.03 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication. The contract, issued on July 21, 2025, with completion targeted for July 22, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,640.36 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,451.37 firm fixed price delivery order is for the supply of Norditropin FlexPro 10 mg/1.5 1.5 ml, a medication used to treat certain medical conditions. The contract has an ultimate completion date of July 16, 2025 and was awarded on July 15, 2025. It is not designated as a set-aside contract, indicating open...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $4,865.02 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 10 mg/1.5 ml medical devices. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,145.42, is for the delivery of Norditropin FlexPro 15 mg/1.5 ml, a medication used to treat growth hormone deficiencies. The contract has an ultimate completion date of April 16, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,600 to Amerisourcebergen Drug Corporation for the supply of Norditropin Flexpro 30 mg/3 ml prefilled syringes. As the prime contractor, Amerisourcebergen will deliver the human growth hormone medication to a location in Conshohocken, Pennsylvania by August 31, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,922.70 for the supply of Norditropin FlexPro 15 mg/1.5 1.5 mL. The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. No set-aside designation was used for this contract...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPLWDelivery Order
The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its DLA contracts, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse medical supply requirements for military and veteran healthcare systems through competitive procurement processes. This specific delivery order for Norditropin, a human growth hormone medication, reflects the company's role in supporting the Defense Health Agency and broader military healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/28/25 |